Table of Contents
Pathology Research International
Volume 2011, Article ID 719139, 9 pages
http://dx.doi.org/10.4061/2011/719139
Research Article

Nanotherapeutics Using an HIV-1 Poly A and Transactivator of the HIV-1 LTR-(TAR-) Specific siRNA

1Division of Allergy, Immunology, and Rheumatology, Department of Medicine, University at Buffalo, The State University of New York, 640 Ellicott Street, Room 444 Innovation Center, Buffalo, NY 14203, USA
2Institute for Lasers, Photonics and Biophotonics, University at Buffalo, The State University of New York, Buffalo, NY 14260, USA

Received 31 December 2010; Accepted 8 March 2011

Academic Editor: J. Stebbing

Copyright © 2011 Supriya D. Mahajan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. B. Ludwig, “RNA silencing and HIV: a hypothesis for the etiology of the severe combined immunodeficiency induced by the virus,” Retrovirology, vol. 5, article 79, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. R. M. Surabhi and R. B. Gaynor, “RNA interference directed against viral and cellular targets inhibits human immunodeficiency virus type 1 replication,” Journal of Virology, vol. 76, no. 24, pp. 12963–12973, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Ui-Tei, Y. Naito, and K. Saigo, “Essential notes regarding the design of functional siRNAs for efficient mammalian RNAi,” Journal of Biomedicine and Biotechnology, vol. 2006, Article ID 65052, 8 pages, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Bannwarth and A. Gatignol, “HIV-1 TAR RNA: the target of molecular interactions between the virus and its host,” Current HIV Research, vol. 3, no. 1, pp. 61–71, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. R. J. Pomerantz, “RNA interference meets HIV-1: will silence be golden?” Nature Medicine, vol. 8, no. 7, pp. 659–660, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Hwang, N. Tamilarasu, K. Ryan et al., “Inhibition of gene expression in human cells through small molecule-RNA interactions,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 23, pp. 12997–13002, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Naito, K. Nohtomi, T. Onogi et al., “Optimal design and validation of antiviral siRNA for targeting HIV-1,” Retrovirology, vol. 4, article 80, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Naito, K. Ui-Tei, T. Nishikawa, Y. Takebe, and K. Saigo, “siVirus: web-based antiviral siRNA design software for highly divergent viral sequences,” Nucleic Acids Research, vol. 34, pp. W448–W450, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. P. N. Prasad, Introduction in Biophotonics, John Wiley & Sons, New York, NY, USA, 2003.
  10. P. N. Prasad, Nanophotonics, John Wiley & Sons, New York, NY, USA, 2004.
  11. J. Qian, K. T. Yong, I. Roy et al., “Imaging pancreatic cancer using surface-functionalized quantum dots,” Journal of Physical Chemistry B, vol. 111, no. 25, pp. 6969–6972, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Park, P. E. Nadeau, and A. Mergia, “Activity of TAR in inducible inhibition of HIV replication by foamy virus vector expressing siRNAs under the control of HIV LTR,” Virus Research, vol. 140, no. 1-2, pp. 112–120, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. K. T. Yong, J. Qian, I. Roy et al., “Quantum rod bioconjugates as targeted probes for confocal and two-photon fluorescence imaging of cancer cells,” Nano Letters, vol. 7, no. 3, pp. 761–765, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Xu, K. T. Yong, I. Roy et al., “Bioconjugated quantum rods as targeted probes for efficient transmigration across an in vitro blood-brain barrier,” Bioconjugate Chemistry, vol. 19, no. 6, pp. 1179–1185, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Bonoiu, S. D. Mahajan, L. Ye et al., “MMP-9 gene silencing by a quantum dot-siRNA nanoplex delivery to maintain the integrity of the blood brain barrier,” Brain Research, vol. 1282, pp. 142–155, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Chomczynski and N. Sacchi, “Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction,” Analytical Biochemistry, vol. 162, no. 1, pp. 156–159, 1987. View at Google Scholar · View at Scopus
  17. S. A. Bustin, “Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems,” Journal of Molecular Endocrinology, vol. 29, no. 1, pp. 23–39, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Radonić, S. Thulke, I. M. Mackay, O. Landt, W. Siegert, and A. Nitsche, “Guideline to reference gene selection for quantitative real-time PCR,” Biochemical and Biophysical Research Communications, vol. 313, no. 4, pp. 856–862, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Bennasser, M. L. Yeung, M. Benkirane, and K. T. Jeang, “RNA interference and HIV-1: hits and misses,” Current Opinion in HIV and AIDS, vol. 1, no. 3, pp. 208–211, 2006. View at Google Scholar
  20. X. Michalet, F. F. Pinaud, L. A. Bentolila et al., “Quantum dots for live cells, in vivo imaging, and diagnostics,” Science, vol. 307, no. 5709, pp. 538–544, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. S. D. Mahajan, I. Roy, G. Xu et al., “Enhancing the delivery of anti retroviral drug “saquinavir” across the blood brain barrier using nanoparticles,” Current HIV Research, vol. 8, no. 5, pp. 396–404, 2010. View at Publisher · View at Google Scholar